Pirozzi Anna Virginia Adriana, Imbimbo Paola, D'Agostino Antonella, Tirino Virginia, Finamore Rosario, Monti Daria Maria, Piccoli Renata, Schiraldi Chiara
Department of Experimental Medicine, Section of Biotechnology, Medical Histology and Molecular Biology, University of Campania "Luigi Vanvitelli", Via De Crecchio 7, 80138 Naples, Italy.
Department of Chemical Sciences, University of Naples Federico II, Via Cinthia 21, 80126 Naples, Italy.
Antioxidants (Basel). 2020 Dec 31;10(1):40. doi: 10.3390/antiox10010040.
Several plant extracts are acquiring increasing value because of their antioxidant activity and hypolipidemic properties. Among them, great interest has been recently paid to açai fruit as a functional food. The aim of this study was to test the ability of açai extract in reducing oxidative stress and modulating lipid metabolism in vitro using different cell models and different types of stress. In fact, lipid peroxidation as evaluated in a HepG2 model was reduced five-fold when using 0.25 µg/mL of extract, and it was further reduced (20-fold) with the concentration increase up to 2.5 µg/mL. With the non alcoholic fatty liver disease (NAFLD)in vitro model, all concentrations tested showed at least a two-fold reduced fat deposit. In addition, primary adipocytes challenged with TNF-α under hypoxic conditions to mimic the persistent subcutaneous fat, treated with açai extract showed an approximately 40% reduction of fat deposit. Overall, our results show that açai is able to counteract oxidative states in all the cell models analysed and to prevent the accumulation of lipid droplets. No toxic effects and high stability overtime were highlighted at the concentrations tested. Therefore, açai can be considered a suitable support in the prevention of different alterations of lipid and oxidative metabolism responsible for fat deposition and metabolic pathological conditions.
几种植物提取物因其抗氧化活性和降血脂特性而具有越来越高的价值。其中,阿萨伊果作为一种功能性食品最近受到了极大关注。本研究的目的是使用不同的细胞模型和不同类型的应激来测试阿萨伊提取物在体外降低氧化应激和调节脂质代谢的能力。事实上,在HepG2模型中评估的脂质过氧化,当使用0.25μg/mL提取物时降低了五倍,随着浓度增加到2.5μg/mL,脂质过氧化进一步降低(二十倍)。在非酒精性脂肪性肝病(NAFLD)体外模型中,所有测试浓度均显示脂肪沉积至少减少了两倍。此外,在缺氧条件下用TNF-α刺激原代脂肪细胞以模拟持续性皮下脂肪,用阿萨伊提取物处理后脂肪沉积减少了约40%。总体而言,我们的结果表明,阿萨伊能够抵消所有分析的细胞模型中的氧化状态,并防止脂质滴的积累。在所测试的浓度下未发现毒性作用,且随着时间推移具有高稳定性。因此,阿萨伊可被认为是预防导致脂肪沉积和代谢病理状况的脂质和氧化代谢不同改变的合适辅助物。